2 completed, 1 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Group 4: new trials by email Literature Review of Group 4 trials Research Report on Group 4
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) iCo-007 350 mcg, iCo-007 700 mcg, iCo-007 350 mcg and Laser - Diabetic Macular Edema | Phase 2 | Terminated | Johns Hopkins University | 185 | 2012-02-01 | 2017-08-30 |
| The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms Placebo, Terazosine, Tolterodine - Disorder of Urinary Stent | Phase 2 / Phase 3 | Completed | Urmia University of Medical Sciences | 104 | 2012-01-01 | 2015-03-02 |
| A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years Vaccine - Meningococcal Vaccine | Phase 2 | Completed | Pfizer | 1714 | 2011-03-03 | 2022-10-27 |
Johns Hopkins University (1) · Pfizer (1) · Urmia University of Medical Sciences (1)
Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Iran (1) · Poland (1) · Spain (1) · Sweden (1) · United States (1)
Ali Tehranchi, Urologist (1) · Brian B. Berger, MD (1) · David Callanan, MD (1) · David M. Brown, MD (1) · Dean Eliott, MD (1) · Dennis M. Marcus, MD (1) · Diana V. Do, MD (1) · Eugene Lit, MD (1) · Goergios Papastergio, MD (1) · Gregg T. Kokame, MD (1) · Henry L. Hudson, MD (1) · Homayoun Tabandeh, MD (1) · Karl G. Csaky, MD, PhD (1) · Larry S. Halperin, MD (1) · Louis Glazer, MD (1)
PMID 26407272, PMID 32681472, PMID 35164991
2009 (1)